Jon Dedon is quoted in an WWD Digital Daily article, discussing how brands selling CBD can and cannot market their product and it’s potential health benefits. On November 25th, the FDA issued warning letters to 15 CBD companies who had marketed their product to alleviate various illnesses or chronic conditions. Health claims such as this,
Perry, among other digital currency experts, was highlighted in a Fintech Zoom article discussing Facebook’s plan to operate its own digital currency. There are concerns about ensuring the privacy of their data, for Facebook does not have a positive track record securing users’ information. Braden Perry – Cybersecurity Attorney, said: The major takeaway is
Garnish and Gather, LLC (“G&G”), a relatively small Georgia company selling meal kits and fresh and prepared foods, has filed a trademark lawsuit in the Southern District of New York against Target Corporation to stop Target’s use of “Good & Gather” as its new in-store food brand. The history and current status of the case
The FDA has announced a major CBD crackdown. In the announcement, the FDA issued its starkest warning yet that it is illegal to sell CBD as a dietary supplement or to add it to human or animal food or beverages, and that companies that break these rules will be subject to major legal consequences. The
Today marks the one year anniversary of the, The Financial Crimes Enforcement Network (“FinCEN”) issuance of Geographic Targeting Orders (“GTOs”) that obligated the U.S. title insurance companies to recognize the natural persons behind shell companies purchasing residential real estate in all cash. For each covered metro area the purchase threshold amount was lowered to $300,000, formerly assorted
The U.S. Commodity Futures Trading Commission (“CFTC”) ordered the filing and finalizing of charges of $67.4 million versus Tower Research Capital LLC, a proprietary trading firm. The CFTC alleged that over a length of almost two years, Tower violated multiple sections of the Commodity Exchange Act by a deceptive and manipulative scheme of spoofing in
Partner Braden Perry, as part of Kennyhertz Perry’s Commodities, Futures, and Derivatives practice group, advises clients on a wide range of commodities and derivatives regulatory matters, and works with companies on compliance with the complex laws and regulations governing the securities and derivatives industries. Perry, a former Commodity Futures Trading Commission (“CFTC”) Senior Trial Attorney
Requirement calls for acceptance of license within 48 hours
Today, the U.S. Department of Agriculture (“USDA”) released a draft version of an interim final rule which, once formally published in the Federal Register, will establish the U.S. Domestic Hemp Production Program. The USDA was directed to develop this Program under the Agricultural Improvement Act of 2018 (which is commonly referred to “2018 Farm Bill”),
The FTC and FDA announced yesterday that they sent yet another joint warning letter to a CBD manufacturer and retailer, warning them that their marketing of CBD products violates federal law. The letter gave the seller 15 days to correct the violations or face “legal action without further notice, including, without limitation, seizure and/or injunction.”
As an attorney who represents several companies before the Federal Trade Commission (“FTC”), Braden Perry offers some of his knowledge in article featured on E-commerce Times website. “This is one of the more common laws that companies run afoul of in the Internet marketing space, according to Kennyhertz Perry partner Braden Perry, who regularly represents companies
The Kansas Legislature is again looking at medical marijuana legalization. On October 23, the Kansas Special Committee on Federal and State Affairs will host an all-day public meeting on medical cannabis. The meeting will take place from at 9:00 a.m. to 5:00 p.m. in the Kansas Statehouse, room 346 South. Although this meeting represents an
